Patient-reported symptom burden in patients with rare cancers receiving pembrolizumab in a phase II Clinical Trial

por Mendoza, Tito R., Hong, David S., Peterson, Christine B., Stephen, Bettzy, Dumbrava, Ecaterina, Pant, Shubbam, Tsimberidou, Apostolia Maria, Yap, Timothy Anthony, Sheshadri, Ajay, Altan, Mehmet, George, Goldy, Castillo, Lilibeth, Rodriguez, Enedelia, Gong, Jing, Subbiah, Vivek, Janku, Filip, Fu, Siqing, Piha-Paul, Sarina A., Ahnert, Jordi Rodon, Karp, Daniel D., Cleeland, Charles, Meric-Bernstam, Funda, Naing, Aung
Publicado 2022

Evaluating the psychometric properties of the Immunotherapy module of the MD Anderson Symptom Inventory

por Mendoza, Tito, Sheshadri, Ajay, Altan, Mehmet, Hess, Kenneth, George, Goldy, Stephen, Bettzy, Castillo, Lilibeth, Rodriguez, Enedelia, Gong, Jing, Peterson, Christine, Rodon Ahnert, Jordi, Fu, Siqing, Piha-Paul, Sarina A, Pant, Shubham, Dumbrava, Ecaterina, Yap, Timonthy A, Janku, Filip, Tsimberidou, Apostolia M, Subbiah, Vivek, Karp, Daniel D, Zarifa, Abdulrazzak, McQuinn, Lacey M, Cleeland, Charles, Hong, David S, Naing, Aung
Publicado 2020